US Patent Issued to IMMUNIS.AI on Jan. 20 for "Methods of detecting prostate cancer" (California, Michigan, Massachusetts, Oregon Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,109, issued on Jan. 20, was assigned to IMMUNIS.AI INC. (Corvallis, Ore.).

"Methods of detecting prostate cancer" was invented by Amin I. Kassis (Chestnut Hill, Mass.), Harry Stylli (La Jolla, Calif.), Colleen Kelly (Carlsbad, Calif.), Geoffrey Erickson (Corvallis, Ore.) and Kirk J. Wojno (Royal Oak, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention described herein provides biological markers for the diagnosis, prognosis, and monitoring of prostate cancer."

The patent was filed on April 20, 2020, under Application No. 16/853,027.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/n...